Literature DB >> 31735952

A new unbiased and highly automated approach to find new prognostic markers in preclinical research.

Martin Neidnicht1, Daniela Mittermüller1, Katharina Effenberger-Neidnicht1.   

Abstract

Data acquisition in (pre)clinical studies is often based on a hypothesis. Numerical algorithms, however, may help to find biomarkers from existing data without formulating any hypothesis. By simply assessing whether a statistical relationship exists between two parameters from a (unlimited) database, every (in)conceivable combination of data becomes a hypothesis. The aim was to create an unbiased and highly automated approach for secondary analysis of (pre)clinical research, including the possibility of a non-linear functional relationship. In our example, an almost homogeneous database was formed by overall 45 parameters (vital, blood and plasma parameters) measured in 11 individual experimental studies at 6 different time points using 57 rats without and 63 rats with systemic inflammation following lipopolysaccharide infusion. For each rat, four group classifiers (treatment, survival, study, ID) were used to get valid samples by a later filtering of the statistical base. Any information about the hypothesis leading to the respective studies was suppressed. In order to assess whether a statistical relationship exists, a total of six different functional prototypes (linear and non-linear) were postulated and examined for their regression. Regression quality, correlation and significance were obtained in form of matrices. In our example, ultimately 510 300 regressions were optimized, automatically evaluated and filtered. The developed algorithm is able to reveal statistical relationships from a nearly crude database with low effort by systematic and unbiased analysis. The finding of well-known correlations proves its reliability, whose validity could be increased by clean aggregation of different studies. In addition, new interesting hints for future research could be gained. Thus, unknown markers can be found which are associated with an increased risk of death during systemic inflammation and sepsis. A further development of the program is planned including multiple regressions (more than two parameters could be related to each other) or cluster analysis.
© The Author(s) 2019. Published by Oxford University Press.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31735952      PMCID: PMC6859257          DOI: 10.1093/database/baz107

Source DB:  PubMed          Journal:  Database (Oxford)        ISSN: 1758-0463            Impact factor:   3.451


  6 in total

Review 1.  Mechanisms of Hemolysis During Sepsis.

Authors:  Katharina Effenberger-Neidnicht; Matthias Hartmann
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

2.  Insights into pH-induced metabolic switch by flux balance analysis.

Authors:  Marija Ivarsson; Heeju Noh; Massimo Morbidelli; Miroslav Soos
Journal:  Biotechnol Prog       Date:  2015-01-30

Review 3.  Big data in medical science--a biostatistical view.

Authors:  Harald Binder; Maria Blettner
Journal:  Dtsch Arztebl Int       Date:  2015-02-27       Impact factor: 5.594

4.  An evaluation of R2 as an inadequate measure for nonlinear models in pharmacological and biochemical research: a Monte Carlo approach.

Authors:  Andrej-Nikolai Spiess; Natalie Neumeyer
Journal:  BMC Pharmacol       Date:  2010-06-07

5.  Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin.

Authors:  José Villagra; Sruti Shiva; Lori A Hunter; Roberto F Machado; Mark T Gladwin; Gregory J Kato
Journal:  Blood       Date:  2007-05-29       Impact factor: 22.113

6.  Moderate glucose supply reduces hemolysis during systemic inflammation.

Authors:  Johannes Jägers; Stephan Brauckmann; Michael Kirsch; Katharina Effenberger-Neidnicht
Journal:  J Inflamm Res       Date:  2018-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.